ZTlido™ (lidocaine topical system) – New drug approval
February 28, 2018 - Sorrento Therapeutics and Scilex Pharmaceuticals announced the FDA approval of ZTlido (lidocaine topical system) 1.8% for the relief of pain associated with post-herpetic neuralgia (PHN).
Download PDF
